EP1904066
COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
6.7.2006:
23.5.2018:
06786496.7
:
5.7.2026
:
COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
6.7.2006
23.5.2018
:
Sunovion Pharmaceuticals Inc.:
84 Waterford Drive, 01752, Marlborough, MA, US
:
CARON, Judy:
Westwood, Massachusetts, US
:
WESSEL, Thomas:
Lenox, Massachusetts, US
:
LALJI, Karim:
West Vancouver, BC V7S 1Z5, CA
:
VARNEY, Mark:
Northborough, Massachusetts, US
:
BAKALE, Roger P.:
Shrewsbury, Massachusetts, US
:
SINGH, Surendra P.:
Shrewsbury, Massachusetts, US
:
WILKINSON, H. Scott:
Westborough, Massachusetts, US
:
SU, Xiping:
Woodbridge, Connecticut, US
:
HAN, Zhengxu:
Shrewsbury, Massachusetts, US
:
KOENIG, Stephan G.:
Shewsbury, Massachusetts, US
:
697013 P:
6.7.2005:
US
:
US2006026361:
6.7.2006
:
A61K 31/135, A61K 31/4985, C07C 211/42, A61P 25/24, A61P 25/28, A61P 25/00